The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Astrazeneca plc ADR’s current trading price is -23.38% away from its 52-week high, while its distance from the 52-week low is 11.10%. The stock’s price
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 0.34%.However, over the last six months,
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 1.40% this year. Over the last six months, there has been
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -2.13%. However, over the last six months,
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -6.12% since the start of this calendar year. Looking back over
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -3.66%. However, over the past six months, we’ve
The stock market performance of Astrazeneca plc ADR has been very steady. Over the last year, the company’s stock hit its highest at $87.68 on 08/30/24, while the lowest price during the same time frame was $60.47, recorded on 02/12/24. 52-week price history of AZN
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Astrazeneca plc ADR’s current trading price is -16.72% away from its 52-week high, while its distance from the 52-week low is 20.75%. The stock’s price
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 12.64% since the start of this calendar year. Looking back
After the German government recommended its administration to people aged 18 to 64 years of age only, AstraZeneca plc (AZN) defended its vaccine’s effectiveness against the new coronavirus in the elderly. A spokesman for the British-Swedish group AstraZeneca plc (AZN) explained that the newest analysis
All rights reserved © 2024, Powered By Smart TechOne
